DENTSPLY SIRONA director awarded 22,822 RSUs

Vergis Janet S. reported acquisition or exercise transactions in this Form 4 filing.

(Neutral)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Vergis Janet S. reported acquisition or exercise transactions in this Form 4 filing.

DENTSPLY SIRONA Inc. director Janet S. Vergis received a grant of 22,822 shares of Common Stock in the form of Restricted Stock Units. The RSUs vest in full one year from the grant date of June 3, 2026. After this award, she directly holds 67,324 shares, reflecting a compensation-related equity grant rather than an open-market purchase or sale.

Insider Trade Summary

Grant/Award: 22,822 shares

Grant/Award 1 txn

Insider Vergis Janet S.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	22,822	$0.00	$0.00

Holdings After Transaction: Common Stock — 67,324 shares (Direct)

Footnotes (1)

F1. This grant consists entirely of Restricted Stock Units (RSUs) that vest in full (restrictions lapse) one year from date of grant.

Key Figures

RSUs granted: 22,822 shares Price per share: $0.00 per share Shares held after grant: 67,324 shares +1 more

4 metrics

RSUs granted 22,822 shares Restricted Stock Units granted on June 3, 2026

Price per share $0.00 per share Grant, award, or other acquisition (code A)

Shares held after grant 67,324 shares Total Common Stock directly owned following transaction

Vesting period One year RSUs vest in full one year from grant date

Key Terms

Restricted Stock Units (RSUs), Grant, award, or other acquisition, Common Stock

3 terms

Restricted Stock Units (RSUs) financial

"This grant consists entirely of Restricted Stock Units (RSUs) that vest in full..."

Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.

Grant, award, or other acquisition financial

"transaction_code_description": "Grant, award, or other acquisition""

Common Stock financial

""security_title": "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did DENTSPLY SIRONA (XRAY) director Janet S. Vergis report on this Form 4?

Janet S. Vergis reported receiving 22,822 shares of DENTSPLY SIRONA Common Stock as a grant of Restricted Stock Units. These RSUs represent equity-based compensation and are not an open-market stock purchase or sale. The award increases her directly held position to 67,324 shares.

Are the DENTSPLY SIRONA (XRAY) shares on this Form 4 a market buy or sell?

The transaction is an equity grant, not a market buy or sell. The Form 4 shows a grant of 22,822 Restricted Stock Units under code “A” for grant, award, or other acquisition, awarded at $0.00 per share as part of director compensation, not through open-market trading.

When do Janet S. Vergis’s DENTSPLY SIRONA (XRAY) RSUs vest?

The Restricted Stock Units granted to Janet S. Vergis vest in full one year from the grant date. The footnote states the grant consists entirely of RSUs whose restrictions lapse after one year, meaning the 22,822 units become fully vested shares at that time, subject to plan terms.

How many DENTSPLY SIRONA (XRAY) shares does Janet S. Vergis hold after this RSU grant?

After the reported grant, Janet S. Vergis directly holds 67,324 shares of DENTSPLY SIRONA Common Stock. This total includes the 22,822 newly granted Restricted Stock Units, which are part of her overall equity position as a company director, according to the Form 4 disclosure.

What does transaction code “A” mean in this DENTSPLY SIRONA (XRAY) Form 4?

Transaction code “A” indicates a grant, award, or other acquisition of securities, rather than an open-market trade. In this filing, it reflects a compensation-related grant of 22,822 Restricted Stock Units to director Janet S. Vergis at $0.00 per share, vesting after one year.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 06/05/2026 - 05:37 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Vergis Janet S.

(Last)

(First)

(Middle)

C/O DENTSPLY SIRONA INC

13320-B BALLANTYNE CORPORATE PLACE

(Street)

CHARLOTTE

NORTH CAROLINA

28277

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
DENTSPLY SIRONA Inc. [ XRAY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/03/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	06/03/2026		A		22,822⁽¹⁾	A	$0	67,324	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. This grant consists entirely of Restricted Stock Units (RSUs) that vest in full (restrictions lapse) one year from date of grant.

	/s/ Jessica Nielsen Causey, Attorney-in-Fact for Janet S. Vergis	06/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR